Amneal Pharmaceuticals is a global biopharmaceutical company specializing in the development, manufacturing, and distribution of generic and specialty medicines, with a strong presence in the U.S., India, and international markets.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Amneal Pharmaceuticals is likely focused on expanding its biosimilars portfolio, investing in complex generics, and enhancing global supply chain resilience in response to evolving healthcare demands.
Launch of new biosimilar products in the U.S. and international markets
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Amneal Pharmaceuticals develops, manufactures, and distributes a broad range of generic and specialty pharmaceutical products, including biosimilars and institutional injectables. Founded by brothers Chirag and Chintu Patel in 2002, the company has grown through strategic acquisitions and a focus on high-quality, affordable medicines. Amneal operates state-of-the-art manufacturing and R&D facilities in the U.S., India, and Ireland, supporting its global reach. The company is committed to innovation, quality, and expanding access to essential medicines.
